U.S. Hyaluronic Acid Market Size & Outlook, 2026-2033
The hyaluronic acid market in the United States is expected to reach a projected revenue of US$ 7,588.0 million by 2033. A compound annual growth rate of 6.8% is expected of the United States hyaluronic acid market from 2026 to 2033.
Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology
Other key industry trends
In terms of revenue, U.S. accounted for 39.0% of the global hyaluronic acid market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. hyaluronic acid market is projected to lead the regional market in terms of revenue in 2033.
Mexico is the fastest growing regional market in North America and is projected to reach USD 240.6 million by 2033.
According to the American Society of Plastic Surgeons (ASPS), over 3.41 million soft tissue filler procedures were performed in 2020, out of which, hyaluronic acid-based dermal fillers were used in 2.61 million procedures.
Increasing popularity of dermal fillers, especially among women with a desire to look attractive, is a key factor expected to boost market growth in the U.S. Increasing number of office video conferences and work from home during COVID-19 pandemic has led to the “Zoom effect” in the cosmetic industry.
Many people are willing to undergo nonsurgical facial esthetic procedures such as dermal fillers or Botox to enhance their appearance during video calls. Cosmetic surgeons in the U.S. are witnessing increase in appointment bookings for such procedures due to “Zoom effect” and the fact that people will be able to stay at home until the swelling disappears.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Hyaluronic Acid Market Outlook will help companies and investors design strategic landscapes.
Dermal Fillers was the largest segment with a revenue share of 55.09% in 2025.
Horizon Databook has segmented the U.S. hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
According to the American Society of Plastic Surgeons (ASPS), over 3.41 million soft tissue filler procedures were performed in 2020, out of which, hyaluronic acid-based dermal fillers were used in 2.61 million procedures.
Increasing popularity of dermal fillers, especially among women with a desire to look attractive, is a key factor expected to boost market growth in the U.S. Increasing number of office video conferences and work from home during COVID-19 pandemic has led to the “Zoom effect” in the cosmetic industry.
Many people are willing to undergo nonsurgical facial esthetic procedures such as dermal fillers or Botox to enhance their appearance during video calls. Cosmetic surgeons in the U.S. are witnessing increase in appointment bookings for such procedures due to “Zoom effect” and the fact that people will be able to stay at home until the swelling disappears.
U.S. Hyaluronic Acid Market Application Outlook (Revenue, USD Million , 2021-2033)
Dermal Fillers
Osteoarthritis
Ophthalmic
Vesicoureteral Reflux
Reasons to subscribe to Hyaluronic Acid Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Hyaluronic Acid Market Outlook databook
Our clientele includes a mix of Hyaluronic Acid Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Hyaluronic Acid Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Hyaluronic Acid Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.